FT Health: Combating Cancer

Have blunt instrument drugs like chemotherapy had their day? Plus: genetic research makes personalised treatments a reality, the push to immunotherapy, apps that extend lives, the scourge of western lifestyles and the ‘toxicity’ of cancer drugs’ cost


Patients with an adverse prognosis may benefit particularly from new genomic approach to disease

High prices subject some patients to long-term collateral damage to incomes and health

Obesity poised to overtake smoking as leading risk factor, warn researchers

Genetic research advances are making truly personalised treatments a reality

Combining established drugs with experimental medicines has raised survival rates

System forewarns doctors when sufferer’s symptoms deteriorate